Litcius/Paper detail

Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection

Diana Zhong, Shaoming Xiao, Amanda K. Debes, Emily Egbert, Patrizio Caturegli, Elizabeth Colantuoni, Aaron M. Milstone

2021JAMA117 citationsDOIOpen Access PDF

Abstract

This study examines antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with prior SARS-CoV-2 infection vs those without infection.

Topics & Concepts

MedicineVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakImmunologyAntibodyVirologyMessenger RNAInternal medicineOutbreakGeneInfectious disease (medical specialty)BiochemistryChemistryDiseaseSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing
Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection | Litcius